Which is more profitable, McKesson or Merck &?

Merck & keeps more of every sale as profit.

Which grows faster, McKesson or Merck &?

McKesson grew its sales faster in recent years.

Which is cheaper, McKesson or Merck &?

Merck & costs less for each unit of yearly profit (lower P/E).

Which has less debt, McKesson or Merck &?

McKesson would need fewer years of earnings to pay off its debt.

McKessonMCKvs

Merck &MRK

McKesson vs Merck & stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

McKesson grows faster and has less debt. Merck & is more profitable and is cheaper for its profits.

Side by side

	McKesson	Merck &
	$127 billion	$364 billion
	1.2%	28.1%
	+11.1%	+9.4%
	26.7×	20.0×
	0.6 years	1.2 years
	81.1%	17.8%
	0.4%	2.8%

Open McKesson Open Merck &

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: McKesson vs Roche · McKesson vs UnitedHealth · McKesson vs AbbVie · McKesson vs Bristol-Myers Squibb · Merck & vs Merck KGaA · Merck & vs Moderna · Merck & vs Pfizer · Merck & vs Regeneron Pharmaceuticals